EFFECT OF YOGA ON PATIENTS WITH ESSENTIAL TREMOR
- Conditions
- Health Condition 1: G250- Essential tremor
- Registration Number
- CTRI/2023/06/053982
- Lead Sponsor
- Department of Swasthavritta and Yoga Faculty of Ayurveda Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Male and female patients fulfilling diagnostic criteria of Essential Tremor (According to Task Force on Tremor of the International Parkinson and Movement Disorder Society- 2018)
2 Patients with ET of age > 18 years to 65 years
3 Patients willing to participate, with their written consent.
4 Patients able to join Yoga Session in online/offline mode.
5 Patients able to follow instructions during Yoga Session.
1 Patients with Essential Tremor of age < 18 years and > 65 years.
2 Patients having any atypical movement disorder (e.g., Essential Tremor in combination with Parkinsonâ??s Disease).
3 Patients with known causes of enhanced physiological tremor viz, current or recent exposure to tremorogenic drugs or presence of drug withdrawal state.
4 Patients with past history of Head Injury, Stroke, Brain or Abdominal Surgery and any abnormal Brain MRI.
5 Patients suffering from any severe disease viz, Chronic Liver disease, Chronic Renal disease, Chronic Musculo-skeletal disorders, Coronary Artery Disease, Cancer, Psychogenic Tremor etc.
6 Patients consuming Alcohol or Anti-Psychotic drugs.
7 Patients unable to complete the questionnaires.
8 Pregnant Women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Essential Tremor severity scale (TETRAs) <br/ ><br>Essential Tremor balance scale (FULLERTON ADVANCED BALANCE SCALE) <br/ ><br>Anxiety and Depression Scale (The Hospital Anxiety and Depression Scale) <br/ ><br>Quality of Life in Essential Tremor Questionnaire (QUEST)Timepoint: The primary outcome of both groups will be assessed at 0 month (baseline), after 1 month (first follow-up), after 2 months (second follow-up), and after 3 months (post-intervention follow-up).
- Secondary Outcome Measures
Name Time Method CBC <br/ ><br>RBS <br/ ><br>LFT <br/ ><br>RFT <br/ ><br>Lipid ProfileTimepoint: The secondary outcome of both groups will be assessed at 0 month (baseline) and after two months (second follow-up).